Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Journal of Cancer|August 19, 2017
Variant CD44 expression is enriching for a cell population with cancer stem cell-like characteristics in human lung adenocarcinomaMakoto Nishino, Mari Ozaki, Ahmed E Hegab, et al.
American Journal of Respiratory Cell and Molecular Biology|February 15, 2018
Intermittent Exposure to Cigarette Smoke Increases Lung Tumors and the Severity of Emphysema More than Continuous ExposureNaofumi Kameyama, Shotaro Chubachi, Ahmed E Hegab, et al.
Journal of Medical Case Reports|October 18, 2012
Tuberous sclerosis diagnosed by incidental computed tomography findings of multifocal micronodular pneumocyte hyperplasia: a case reportMakoto Ishii, Koichiro Asano, Nobufumi Kamiishi, et al.
Respiratory Medicine Case Reports|June 7, 2024
A case of autoimmune pulmonary alveolar proteinosis responding to oral statin therapySo Shimamura, Honami Morikawa, Ken Shinohara, et al.
Molecular Cancer Therapeutics|February 23, 2018
Pharmacological and Structural Characterizations of Naquotinib, a Novel Third-Generation EGFR Tyrosine Kinase Inhibitor, in EGFR-Mutated Non-Small Cell Lung CancerToshiyuki Hirano, Hiroyuki Yasuda, Junko Hamamoto, et al.
International Journal of Oncology|October 30, 2014
Long‑term exposure to gefitinib induces acquired resistance through DNA methylation changes in the EGFR‑mutant PC9 lung cancer cell lineHideki Terai, Kenzo Soejima, Hiroyuki Yasuda, et al.
Lung Cancer (Amsterdam, Netherlands)|June 5, 2017
Clinical and pathological characteristics of EGFR mutation in operable early-stage lung adenocarcinomaMasaya Yotsukura, Hiroyuki Yasuda, Takao Shigenobu, et al.
Journal of Leukocyte Biology|March 17, 2004
MCP-1-dependent signaling in CCR2(-/-) aortic smooth muscle cellsAlison D Schecter, Adriane B Berman, Lin Yi, et al.
International Journal of Oncology|October 30, 2014
Multiple roles of extracellular fibroblast growth factors in lung cancer cellsTakahiro Suzuki, Hiroyuki Yasuda, Koji Funaishi, et al.
Molecular and Clinical Oncology|October 5, 2016
Successful treatment of non-small-cell lung cancer with afatinib and a glucocorticoid following gefitinib- and erlotinib-induced interstitial lung disease: A case reportTetsuo Tani, Katsuhiko Naoki, Takanori Asakura, et al.
Pageof 13